{"id":"W3042325035","doi":"10.1186/s13045-020-00929-8","title":"Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy","year":2020,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"Daiichi Sankyo Europe; Incyte; Agios Pharmaceuticals; Jazz Pharmaceuticals; European Hematology Association; Celgene; Gilead Sciences; Servier; Ariad Pharmaceuticals; Amgen; Pfizer; Astellas Pharma","keywords":"Medicine; Internal medicine; Cytarabine; Hazard ratio; Myeloid leukemia; Clinical trial; Oncology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006207774,0.000254764,0.001049152,0.0001441997,0.00006180465,0.00001321851,0.0001796405,0.0002446997,0.00000256446],"category_scores_gemma":[0.0004429693,0.000171746,0.00006531657,0.0001830279,0.000174563,0.00001010962,0.000156621,0.0002852344,0.000002040597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006200972,"about_ca_system_score_gemma":0.0002976642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001051102,"about_ca_topic_score_gemma":0.0001135194,"domain_scores_codex":[0.9981433,0.0003340465,0.0006609466,0.0003975196,0.000144596,0.0003195774],"domain_scores_gemma":[0.9986444,0.0003236785,0.0003071514,0.0001576911,0.0002500576,0.0003170401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03966797,0.0001663209,0.9376588,0.00000867348,0.0005805231,0.0003931863,0.0003328095,0.00004738508,0.01870366,0.000007605177,0.00009948547,0.002333584],"study_design_scores_gemma":[0.01322205,0.02799568,0.9492784,0.00005458741,0.0001050226,0.0003162173,0.0004177372,0.000006541238,0.006401039,0.000006401163,0.001913221,0.0002831062],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99468,0.0002459026,0.000127635,0.004502644,0.00008962556,0.0003204184,0.000009346943,0.000006762534,0.00001765499],"genre_scores_gemma":[0.9954594,0.0001901176,0.001817055,0.002406284,0.00006826653,0.000009623267,0.000004327198,0.00002899569,0.00001586744],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02782936,"threshold_uncertainty_score":0.7003599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0201375483975543,"score_gpt":0.3132000009129852,"score_spread":0.2930624525154308,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}